𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

✍ Scribed by Paul B Chapman; Linda Williams; Nadia Salibi; Wen-Jen Hwu; Susan E Krown; Philip O Livingston


Book ID
116957166
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
129 KB
Volume
22
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.